Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism.

Valérie Ugo; Grégoire Le Gal; L. Lecucq; Dominique Mottier; Emmanuel Oger

doi:10.1111/j.1538-7836.2007.02811.x

Journal articles

Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism.

Valérie Ugo ¹ Grégoire Le Gal ² L. Lecucq ³ Dominique Mottier ^{4, 2} Emmanuel Oger

1 Laboratoire d'Hématologie Biologique

2 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale

3 CHU-Brest-Hemato - CHRU Brest - Service d'Hématologie

4 CIC - Brest - Centre d'Investigation Clinique

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology

Complete list of metadata

https://hal.univ-brest.fr/hal-00683395
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Wednesday, March 28, 2012 - 3:51:51 PM
Last modification on : Thursday, March 31, 2022 - 11:00:02 AM

Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism.

Identifiers

Collections

Citation

Export

Metrics

22

Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism.

Identifiers

Collections

Citation

Export

Share

Metrics

22